carosel1

Click here to view original web page at Bipolar Disorder Market Size & Share is Expected to reach USD 5.56 Billion by 2030, to grow at a CAGR of 3.1% “According to the research report published by Polaris Market Research, the global bipolar disorder market was valued at USD 4.28 billion in 2021 and is … Continue reading "Bipolar Disorder Market Size & Share is Expected to reach USD 5.56 Billion by 2030, to grow at a CAGR of 3.1%"

Click here to view original web page at Top January 2023 FDA Approvals Adacel is administered as a single 0.5-mL intramuscular injection. To start the New Year, the US Food and Drug Administration (FDA) has approved drugs relevant to conditions often treated by nurse practitioners and PAs. Approvals include treatments for schizophrenia and bipolar disorder, … Continue reading "Top January 2023 FDA Approvals"

Click here to view original web page at Childhood, Adolescent Cancers Linked to Higher Risk of Major Psychiatric Disorders Cancer survivors had an increased risk of autism spectrum disorder, ADHD, PTSD, OCD, major depressive disorder, and bipolar disorder. Compared with the general population, survivors of childhood and adolescent cancers have an increased risk of 6 … Continue reading "Childhood, Adolescent Cancers Linked to Higher Risk of Major Psychiatric Disorders"

Click here to view original web page at FDA approves Luye Pharma’s Rykindo for the treatment of schizophrenia and bipolar 1 disorder FDA approves Luye Pharma’s Rykindo for the treatment of schizophrenia and bipolar 1 disorder PRINCETON, N.J., Jan. 15, 2023 /PRNewswire/ — Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the … Continue reading "FDA approves Luye Pharma’s Rykindo for the treatment of schizophrenia and bipolar 1 disorder"

Click here to view original web page at Psychedelic therapies make inroads in the American West In several states, compounds in hallucinogenic mushrooms are being used to treat Parkinson’s, bipolar disorder, chronic pain and other diseases Participants receive training to become state-certified psilocybin facilitators, in Portland, Oregon on December 2, 2022.Amanda Lucier (ContactoPhoto) Psilocybin – … Continue reading "Psychedelic therapies make inroads in the American West"

Click here to view original web page at How differences in diagnoses of mental disorders might affect clinical research outcomes for antipsychotics Patients with bipolar disorder who exhibited psychotic features derived a clear benefit from antipsychotic drugs (a) but not from mood stabilizers (b). Credit: Taro Kishi, Fujita Health University School of Medicine Most physical … Continue reading "How differences in diagnoses of mental disorders might affect clinical research outcomes for antipsychotics"

Click here to view original web page at How differences in diagnoses of mental disorders might affect clinical research outcomes for antipsychotics Mental illnesses often have unclear definitions, and their diagnosis and treatment are susceptible to subjective interpretation. Japanese researchers have now clarified an important confounding factor in the evaluation of antipsychotics Peer-Reviewed Publication Fujita … Continue reading "How differences in diagnoses of mental disorders might affect clinical research outcomes for antipsychotics"

Click here to view original web page at How differences in diagnoses of mental disorders might affect clinical research outcomes for antipsychotics Patients with bipolar disorder who exhibited psychotic features derived a clear benefit from antipsychotic drugs (a) but not from mood stabilizers (b). Credit: Taro Kishi, Fujita Health University School of Medicine Most physical … Continue reading "How differences in diagnoses of mental disorders might affect clinical research outcomes for antipsychotics"

Click here to view original web page at The Neuronal Basis of Impaired Consciousness in Absence Epilepsy Summary: During absence seizures, most neurons showed decreased activity. This, researchers say, explains the decrease in brain function and impaired consciousness during an absence epilepsy seizure. Source: Yale Imagine slipping in and out of consciousness hundreds of times … Continue reading "The Neuronal Basis of Impaired Consciousness in Absence Epilepsy"

Click here to view original web page at Cannabis Has Unique Benefits For People With Bipolar Disorder, Says New Medical Research FREE REPORT: Today only, get access to our leading Pro Insider Report for FREE (no credit card required) This article was originally published on Cannabis.net and appears here with permission. Around 46 million people … Continue reading "Cannabis Has Unique Benefits For People With Bipolar Disorder, Says New Medical Research"

Click here to view original web page at 7 Nutrient-Packed Foods for People With Bipolar Disorder Certain nutrients found in citrus fruits, nuts, and seafood may be beneficial for people with bipolar disorder, experts say. Someone with bipolar disorder — formerly known as manic depression — typically experiences extreme shifts in mood and energy levels. … Continue reading "7 Nutrient-Packed Foods for People With Bipolar Disorder"

Click here to view original web page at The Bipolar Spectrum: The Different Types of Bipolar Disorder Bipolar disorder is a serious clinical entity that often generates bewilderment and fear. In addition, there are up to nine different forms of bipolar disorder. In this article, we’re going to explain the different types. Bipolar disorder is … Continue reading "The Bipolar Spectrum: The Different Types of Bipolar Disorder"

Click here to view original web page at Sleep spindles in people with schizophrenia, schizoaffective disorders or bipolar disorders: a pilot study in a general population-based cohort Abstract Background Sleep spindles have been involved in sleep stabilization and sleep-related memory mechanisms and their deficit emerged as possible biomarker in schizophrenia. However, whether this sleep phenotype … Continue reading "Sleep spindles in people with schizophrenia, schizoaffective disorders or bipolar disorders: a pilot study in a general population-based cohort"